
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 366-375
Open Access | Times Cited: 275
Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 366-375
Open Access | Times Cited: 275
Showing 1-25 of 275 citing articles:
Determinants of COVID-19 vaccine fatigue
Tanja Stamm, Julia Partheymüller, Erika Mosor, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1164-1171
Open Access | Times Cited: 54
Tanja Stamm, Julia Partheymüller, Erika Mosor, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1164-1171
Open Access | Times Cited: 54
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023
Jeffrey V. Lazarus, Trenton M. White, Katarzyna Wyka, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1559-1563
Open Access | Times Cited: 25
Jeffrey V. Lazarus, Trenton M. White, Katarzyna Wyka, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1559-1563
Open Access | Times Cited: 25
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F. Luetkemeyer, Kara W. Chew, Stuart R. Lacey, et al.
Clinical Infectious Diseases (2025)
Open Access | Times Cited: 1
Anne F. Luetkemeyer, Kara W. Chew, Stuart R. Lacey, et al.
Clinical Infectious Diseases (2025)
Open Access | Times Cited: 1
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Fengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 12, pp. 1075-1088
Open Access | Times Cited: 31
Fengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 12, pp. 1075-1088
Open Access | Times Cited: 31
The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study
James Wambua, Neilshan Loedy, Christopher I Jarvis, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
James Wambua, Neilshan Loedy, Christopher I Jarvis, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Dynamic predictors of COVID-19 vaccination uptake and their interconnections over two years in Hong Kong
Jiehu Yuan, Yucan Xu, Irene Wong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Jiehu Yuan, Yucan Xu, Irene Wong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis
Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e54769-e54769
Open Access | Times Cited: 11
Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e54769-e54769
Open Access | Times Cited: 11
SARS-CoV-2 correlates of protection from infection against variants of concern
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 8
Kaiyuan Sun, Jinal N. Bhiman, Stefano Tempia, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2805-2812
Closed Access | Times Cited: 8
Divergent COVID-19 vaccine policies: Policy mapping of ten European countries
Robin van Kessel, Rebecca Forman, Ricarda Milstein, et al.
Vaccine (2023) Vol. 41, Iss. 17, pp. 2804-2810
Open Access | Times Cited: 19
Robin van Kessel, Rebecca Forman, Ricarda Milstein, et al.
Vaccine (2023) Vol. 41, Iss. 17, pp. 2804-2810
Open Access | Times Cited: 19
Active Enrichment of Nanoparticles for Ultra-Trace Point-of-Care COVID-19 Detection
Yong Luo, Mengyun Zhou, Chuan Fan, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 12, pp. 5316-5322
Closed Access | Times Cited: 18
Yong Luo, Mengyun Zhou, Chuan Fan, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 12, pp. 5316-5322
Closed Access | Times Cited: 18
A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah I. Tsiga-Ahmed, et al.
Nature Human Behaviour (2023) Vol. 8, Iss. 1, pp. 100-114
Open Access | Times Cited: 16
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah I. Tsiga-Ahmed, et al.
Nature Human Behaviour (2023) Vol. 8, Iss. 1, pp. 100-114
Open Access | Times Cited: 16
Public preferences for vaccination campaigns in the COVID-19 endemic phase: insights from the VaxPref database
Marcello Antonini, Mesfin G. Genie, Arthur E. Attema, et al.
Health Policy and Technology (2024) Vol. 13, Iss. 1, pp. 100849-100849
Open Access | Times Cited: 5
Marcello Antonini, Mesfin G. Genie, Arthur E. Attema, et al.
Health Policy and Technology (2024) Vol. 13, Iss. 1, pp. 100849-100849
Open Access | Times Cited: 5
Mechanisms Driving Online Vaccine Debate During the COVID-19 Pandemic
Ozgur Can Seckin, A. Selin Atalay, Ege Otenen, et al.
Social Media + Society (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Ozgur Can Seckin, A. Selin Atalay, Ege Otenen, et al.
Social Media + Society (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Hesitação vacinal infantil e COVID-19: uma análise a partir da percepção dos profissionais de saúde
Ester Paiva Souto, Michelle Fernández, Celita Almeida Rosário, et al.
Cadernos de Saúde Pública (2024) Vol. 40, Iss. 3
Open Access | Times Cited: 5
Ester Paiva Souto, Michelle Fernández, Celita Almeida Rosário, et al.
Cadernos de Saúde Pública (2024) Vol. 40, Iss. 3
Open Access | Times Cited: 5
Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 5
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 5
A systematic review of measures of healthcare workers’ vaccine confidence
Kofoworola O. Akinsola, Ayobami A. Bakare, Elisa Gobbo, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Kofoworola O. Akinsola, Ayobami A. Bakare, Elisa Gobbo, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Vaccine hesitancy and trust in sub-Saharan Africa
Kerstin Unfried, Jan Priebe
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Kerstin Unfried, Jan Priebe
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era
Grazia Pavia, Francesco Branda, Alessandra Ciccozzi, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 847-847
Open Access | Times Cited: 5
Grazia Pavia, Francesco Branda, Alessandra Ciccozzi, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 847-847
Open Access | Times Cited: 5
Beyond the records: Data quality and COVID-19 vaccination progress in low- and middle-income countries
Yannick Markhof, Philip Wollburg, Alberto Zezza
Journal of Development Economics (2025) Vol. 174, pp. 103449-103449
Open Access
Yannick Markhof, Philip Wollburg, Alberto Zezza
Journal of Development Economics (2025) Vol. 174, pp. 103449-103449
Open Access
COVID-19 Vaccine Hesitancy Among Various Segments of the Population in Turkey: A Literature Review
Sezer Okay
Vaccines (2025) Vol. 13, Iss. 1, pp. 44-44
Open Access
Sezer Okay
Vaccines (2025) Vol. 13, Iss. 1, pp. 44-44
Open Access
Factors influencing COVID-19 vaccine acceptability among household heads in northern Nigeria: a community-based cross-sectional study
Suleiman Idris Ahmad, Hafiz Aliyu, Rabi Usman, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e083470-e083470
Open Access
Suleiman Idris Ahmad, Hafiz Aliyu, Rabi Usman, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e083470-e083470
Open Access
Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China
Yuxi Liu, Yanlin Cao, Yugang Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Yuxi Liu, Yanlin Cao, Yugang Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Are we Ready for the Next Pandemic? Public Preferences and Trade-offs Between Vaccine Characteristics and Societal Restrictions Across 21 countries
Marcello Antonini, Mesfin G. Genie, Katie Attwell, et al.
Social Science & Medicine (2025) Vol. 366, pp. 117687-117687
Open Access
Marcello Antonini, Mesfin G. Genie, Katie Attwell, et al.
Social Science & Medicine (2025) Vol. 366, pp. 117687-117687
Open Access
Inequality in COVID-19 vaccine acceptance and uptake: A repeated cross-sectional analysis of COVID vaccine acceptance and uptake in 13 countries
Zachary D V Abel, Laurence S. J. Roope, Raymond Duch, et al.
Health Policy (2025) Vol. 153, pp. 105251-105251
Open Access
Zachary D V Abel, Laurence S. J. Roope, Raymond Duch, et al.
Health Policy (2025) Vol. 153, pp. 105251-105251
Open Access